S&P 500   3,467.26 (+1.18%)
DOW   28,496.39 (+1.07%)
QQQ   286.01 (+0.78%)
AAPL   118.31 (+2.01%)
MSFT   215.57 (+0.63%)
FB   267.64 (+2.39%)
GOOGL   1,549.32 (+1.27%)
AMZN   3,233.77 (+0.83%)
TSLA   426.23 (-1.07%)
NVDA   546.92 (+1.30%)
BABA   310.61 (+1.74%)
CGC   19.13 (-3.43%)
GE   7.36 (+0.96%)
MU   54.06 (+2.72%)
AMD   82.07 (+0.09%)
T   26.94 (+0.22%)
F   7.84 (+3.29%)
ACB   4.49 (-4.67%)
GILD   60.38 (-0.31%)
NFLX   529.38 (-0.25%)
BA   168.37 (+0.75%)
BAC   24.35 (+2.66%)
DIS   124.88 (+0.52%)
S&P 500   3,467.26 (+1.18%)
DOW   28,496.39 (+1.07%)
QQQ   286.01 (+0.78%)
AAPL   118.31 (+2.01%)
MSFT   215.57 (+0.63%)
FB   267.64 (+2.39%)
GOOGL   1,549.32 (+1.27%)
AMZN   3,233.77 (+0.83%)
TSLA   426.23 (-1.07%)
NVDA   546.92 (+1.30%)
BABA   310.61 (+1.74%)
CGC   19.13 (-3.43%)
GE   7.36 (+0.96%)
MU   54.06 (+2.72%)
AMD   82.07 (+0.09%)
T   26.94 (+0.22%)
F   7.84 (+3.29%)
ACB   4.49 (-4.67%)
GILD   60.38 (-0.31%)
NFLX   529.38 (-0.25%)
BA   168.37 (+0.75%)
BAC   24.35 (+2.66%)
DIS   124.88 (+0.52%)
S&P 500   3,467.26 (+1.18%)
DOW   28,496.39 (+1.07%)
QQQ   286.01 (+0.78%)
AAPL   118.31 (+2.01%)
MSFT   215.57 (+0.63%)
FB   267.64 (+2.39%)
GOOGL   1,549.32 (+1.27%)
AMZN   3,233.77 (+0.83%)
TSLA   426.23 (-1.07%)
NVDA   546.92 (+1.30%)
BABA   310.61 (+1.74%)
CGC   19.13 (-3.43%)
GE   7.36 (+0.96%)
MU   54.06 (+2.72%)
AMD   82.07 (+0.09%)
T   26.94 (+0.22%)
F   7.84 (+3.29%)
ACB   4.49 (-4.67%)
GILD   60.38 (-0.31%)
NFLX   529.38 (-0.25%)
BA   168.37 (+0.75%)
BAC   24.35 (+2.66%)
DIS   124.88 (+0.52%)
S&P 500   3,467.26 (+1.18%)
DOW   28,496.39 (+1.07%)
QQQ   286.01 (+0.78%)
AAPL   118.31 (+2.01%)
MSFT   215.57 (+0.63%)
FB   267.64 (+2.39%)
GOOGL   1,549.32 (+1.27%)
AMZN   3,233.77 (+0.83%)
TSLA   426.23 (-1.07%)
NVDA   546.92 (+1.30%)
BABA   310.61 (+1.74%)
CGC   19.13 (-3.43%)
GE   7.36 (+0.96%)
MU   54.06 (+2.72%)
AMD   82.07 (+0.09%)
T   26.94 (+0.22%)
F   7.84 (+3.29%)
ACB   4.49 (-4.67%)
GILD   60.38 (-0.31%)
NFLX   529.38 (-0.25%)
BA   168.37 (+0.75%)
BAC   24.35 (+2.66%)
DIS   124.88 (+0.52%)
Log in

UK Space Agency backs medical drone delivery project

Saturday, October 17, 2020 | The Associated Press

LONDON (AP) — A medical drone delivery service founded by trainee doctors that aims to transport coronavirus samples, test kits and protective equipment between hospitals has won the backing of Britain’s Space Agency.

The start-up project can help free up healthcare staff, avoid courier waiting times and minimize the risk of virus transmission, authorities said Saturday.

Trainee doctors Hammad Jeilani and Christopher Law are trialing “dronepad” infrastructure so the miniature aircraft can take off from and land on hospitals, laboratories and warehouses. They are planning to scale up the trials and set up a nationwide network of secure air corridors to enable the drone delivery service to work safely across National Health Service sites.

The hybrid drones — which have the rotors of a typical drone and the wings of a plane — can carry a maximum of 2 kilograms (4.4 pounds) and fly about 60 miles (96 kilometers.)

The drone project is among others set to share 1.3 million pounds ($1.7 million) of funding from the U.K. Space Agency and the European Space Agency to businesses developing space-based solutions for challenges created by Covid-19.

20 Stocks to Sell Now

Most people know that brokerage rankings are overstated because of pressure from publicly-traded companies. No investor relations person wants to see "hold" and "sell" ratings issued for their stock. In reality, a "buy" rating really means "hold." "Hold" ratings really mean "sell" and "sell" ratings mean get out while you still can.

If Wall Street's top analysts are consistently giving "hold" and "sell" ratings to a stock, you know there's a serious problem. We've compiled a list of the companies that Wall Street's top equities research analysts are consistently giving "hold" and "sell" ratings too. If you own one of these stocks, consider getting out while there's still time.

This slide show lists the 20 companies that have the lowest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.

View the "20 Stocks to Sell Now".

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.